Paramedic Papers

Home Stroke & neuro IM midazolam non-inferior for prehospital seizures

Stroke & neuro

IM midazolam non-inferior for prehospital seizures

Intramuscular midazolam versus intravenous clonazepam for prehospital treatment of generalized tonic-clonic seizures: A randomized double-blind non-inferiority trial
Seizure: European Journal of Epilepsy · Added 27 August 2026

Randomised double-blind non-inferiority trial testing whether IM midazolam is non-inferior to IV clonazepam for prehospital seizures — it was, with 75% treatment success for IM midazolam versus 62.5% for IV clonazepam (risk difference +12.5 percentage points; 95% CI -10.0 to +33.4).

Study type
RCT
Design
Randomised double-blind non-inferiority trial (physician-staffed EMS, Tunis)
Participants
64 patients aged ≥14 with witnessed tonic-clonic seizures ≥5 min (32 per group)
Main finding
Treatment success 75% IM midazolam vs 62.5% IV clonazepam (risk difference +12.5 pp; 95% CI -10.0 to +33.4), meeting non-inferiority; time to seizure cessation shorter with IM midazolam (1:42 vs 3:13 min)
Caveat
Small sample; wide confidence interval; physician-staffed Tunisian system may not generalise
Bottom line
Hypothesis-generating

Why it matters in Australia (High relevance). Directly relevant to prehospital seizure management — IM midazolam is widely used in Australia and this RCT supports its use when IV access would delay treatment.

Learning goal

Weigh intramuscular midazolam against intravenous benzodiazepines for prehospital seizure control in my practice.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Stroke & neuro